📚 Central Nervous System Special Senses Module L2 Brain Metabolism Without Csf

📚 Lecture Overview

This lecture covers the fundamental metabolic features of the human brain, focusing on glucose, ketone body, and glutamate metabolism under physiological, fasting, and hypoglycemic states. It explains the biochemical mechanisms underlying neurotoxicity, excessive excitation, and hyperammonemia in the central nervous system. Additionally, it details the functional characteristics of the blood-brain barrier and highlights clinical protein markers released into the cerebrospinal fluid during CNS pathology.

🎯 Key Concepts & Definitions

• GLUT 3: An insulin-independent glucose transporter with a low $K_m$ value, ensuring saturated transport and a continuous supply of glucose to the brain even during reduced blood glucose levels.
• Glutamine Synthetase: An essential astrocyte enzyme that converts glutamate and ammonia into glutamine, serving as the main mechanism for ammonia detoxification in the brain.
• Excitotoxicity: Functional and structural neuronal damage resulting from excessive glutamate release or impaired reuptake, causing prolonged postsynaptic depolarization.
• Blood-Brain Barrier (BBB): A selective, size-dependent permeability barrier that restricts large molecules (such as albumin-bound fatty acids) while allowing essential nutrients like glucose to cross.

📖 Main Content

1. Brain Energy Metabolism & Substrate Utilization

• The brain constitutes 2% of total body mass but produces and utilizes about 10 times more energy than other body tissues under resting conditions.
• Main Uses of Energy:
• Synthesis and release of neurotransmitters.
• Synthesis of receptor proteins.
• Powering the active $Na^+$-$K^+$ transport mechanism to maintain the membrane potential required for nerve impulse transmission.
• Glucose Utilization:
• Glucose is virtually the sole energy fuel for the brain (~120 g daily).
• The brain has essentially no glucose reserve and relies on continuous blood supply from the liver.
• Transport into brain cells occurs via facilitated diffusion using GLUT 1 and GLUT 3 (both are insulin-independent).
• Hypoglycemia:
• Glycolysis slows when blood glucose drops near the $K_m$ value of hexokinase (~39.6 mg/dL).
• Severe hypoglycemia is defined as 40 mg/dL and below.
• Symptoms include anxiety, panic, sleep disturbances, night sweats, and vivid unpleasant dreams (e.g., nocturnal hypoglycemia in type 1 diabetes).
• Fatty Acids vs. Ketone Bodies:
• Free Fatty Acids: Cannot be used for energy because neurons lack fatty acid oxidation enzymes and plasma free fatty acids are bound to albumin, preventing them from crossing the BBB.
• Ketone Bodies: During prolonged starvation, the brain adapts to utilize ketone bodies (specifically $\beta$-hydroxybutyric acid) produced by the liver, sparing muscle proteins from gluconeogenesis.

2. Glutamate Metabolism and Neurotoxicity

• Sources of Brain Glutamate:
  1. Uptake from the blood amino acid pool.
  2. Synthesis from $\alpha$-ketoglutarate by transamination or glutamate dehydrogenase.
  3. Synthesis from glutamine catalyzed by glutaminase.
• Fates of Brain Glutamate:
• Conversion to glutamine via glutamine synthetase (ammonia detoxification).
• Decarboxylation to GABA via L-glutamate decarboxylase.
• Release into the synaptic cleft for excitatory neurotransmission (involved in learning, memory, and cognition), followed by rapid uptake into astrocytes.
• Excitotoxicity Conditions:
• Caused by excessive glutamate release or impaired reuptake during cerebral ischemia, hypoglycemia, neurotoxins, or epilepsy.
• Ammonia Intoxication (Hyperammonemia):
• Normal blood ammonia is $< 50 \mumol/L$. Levels $> 200 \mumol/L$ lead to seizures, coma, and death.
• Mechanisms of Neurotoxicity:
  1. Cerebral Edema: Increased glutamine in astrocytes acts as an osmotically active solute, causing water influx and astrocyte swelling.
  2. ATP Depletion: Excessive conversion of $\alpha$-ketoglutarate to glutamate/glutamine depletes citric acid cycle (TCA cycle) intermediates.
  3. Neurotransmitter Depletion: Depletion of glutamate and GABA.

3. Blood-Brain Barrier & Diagnostic CSF Protein Markers

• The BBB is a relative barrier determined by molecular size (e.g., only 1 in 200 serum albumin molecules passes into normal CSF).
• Approximately 15% of the CSF protein pool is synthesized within the brain (e.g., prostaglandin D synthase, cystatin C, transthyretin/prealbumin).
• Pathologic Protein Markers in CSF:

📊 Visual Learning

💡 Important Points to Remember

• The brain consumes approximately 120 g of glucose daily and contains essentially no glucose reserve.
• Glucose uptake by GLUT 1 and GLUT 3 is entirely insulin-independent.
• GLUT 3 has a low $K_m$ for glucose, ensuring continuous glucose saturation even when blood levels drop.
• Severe hypoglycemia occurs at 40 mg/dL and below (hexokinase $K_m$ is reached at ~39.6 mg/dL).
• Direct oxidation of plasma free fatty acids does not occur in neurons due to a lack of oxidation enzymes and BBB impermeability to albumin.
• $\beta$-hydroxybutyric acid is the specific ketone body utilized by the brain during prolonged fasting.
• Glutamine synthetase in astrocytes provides the primary detoxification pathway for ammonia in the brain.
• Ammonia neurotoxicity depletes $\alpha$-ketoglutarate from the TCA cycle, significantly reducing ATP production.
• Neuron-specific enolase is a marker for brain death; GFAP indicates astrocyte scarring/plaques.
• Myelin basic protein in CSF is a hallmark marker of demyelinating diseases.

⚠️ Common Exam Questions

Exam Traps & MCQ Tricks

• Trap 1: Fatty Acid Utilization in Starvation
• Examiner Trick: Questions may claim that during starvation, the brain directly oxidizes free fatty acids from blood plasma.
• Fact: Neurons cannot utilize free fatty acids. They utilize ketone bodies (specifically $\beta$-hydroxybutyric acid) formed by the liver.
• Trap 2: Insulin Dependency
• Examiner Trick: Options stating that brain glucose uptake decreases in type 1 diabetes due to lack of insulin.
• Fact: Brain glucose transporters (GLUT 1 and GLUT 3) are insulin-independent.
• Trap 3: Mechanism of Hyperammonemic Energy Failure
• Examiner Trick: Attributing low brain ATP in hyperammonemia to direct inhibition of hexokinase.
• Fact: Low ATP is caused by the depletion of $\alpha$-ketoglutarate from the TCA cycle to synthesize glutamate and glutamine.
• Trap 4: Cell Marker Matching
• Examiner Trick: Swapping cell types and their pathologic markers (e.g., matching Myelin Basic Protein to astrocytes or GFAP to oligodendrocytes).
• Fact: Oligodendrocyte = Myelin Basic Protein (demyelination); Astrocyte = GFAP (scar/plaque); Microglia = Ferritin (stroke); Choroid plexus = Asialotransferrin (CSF leak).

📝 Quick Review Checklist

I can explain why the brain cannot utilize free fatty acids directly for energy.
I understand how GLUT 3 properties protect the brain during moderate drops in blood glucose.
I can state the exact blood glucose threshold for severe hypoglycemia ($≤ 40 mg/dL$).
I can describe the two primary mechanisms of ammonia neurotoxicity in the brain.
I can list all 5 cell-specific CSF protein markers and their corresponding pathological conditions.
I know the enzymes involved in converting glutamate to glutamine and GABA.